12 Baillie Gifford Burning Rock Biotech Ltd Trades
Baillie Gifford started to build up the position in Burning Rock Biotech Ltd in Q2 2020 and continued to invest until Q1 2022. Since then they sold 891 Thousand shares. The investor completely sold their stake between Q2 2022 and Q4 2023.
Avg closing price
Price range
Sold -15.7 Thousand shares
Q4 2023
Avg closing price
$0.92
Price range
$0.72
-
$1.13
Sold 2.0% shares (-326 shares)
Q3 2023
Avg closing price
$1.56
Price range
$0.91
-
$2.29
Sold 52.6% shares (-17.8 Thousand shares)
Q3 2022
Avg closing price
$3.23
Price range
$2.39
-
$3.96
Sold 96.2% shares (-857 Thousand shares)
Q2 2022
Avg closing price
$4.47
Price range
$1.75
-
$10.44
Increased shares by 0.1% (+1.08 Thousand shares)
Q1 2022
Avg closing price
$8.69
Price range
$6.70
-
$10.23
Increased shares by 1.2% (+10.8 Thousand shares)
Q4 2021
Avg closing price
$13.70
Price range
$9.43
-
$17.14
Increased shares by 3.9% (+33 Thousand shares)
Q3 2021
Avg closing price
$22.23
Price range
$17.37
-
$27.92
Increased shares by 28.6% (+188 Thousand shares)
Q2 2021
Avg closing price
$29.59
Price range
$26.14
-
$37.45
Increased shares by 317.2% (+500 Thousand shares)
Q1 2021
Avg closing price
$30.44
Price range
$23.50
-
$39.58
Increased shares by 55.8% (+56.5 Thousand shares)
Q4 2020
Avg closing price
$26.85
Price range
$22.55
-
$30.87
Increased shares by 40.9% (+29.4 Thousand shares)
Q3 2020
Avg closing price
$23.70
Price range
$19.07
-
$29.61
New holding (+71.9 Thousand shares)
Q2 2020
Avg closing price
$27.41
Price range
$23.21
-
$31.43
